190 related articles for article (PubMed ID: 21176549)
1. [Clinical significance of the revised international federation of gynecology and obstetrics staging system 2009].
Shen K; Peng P; Wu M
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):721-4. PubMed ID: 21176549
[No Abstract] [Full Text] [Related]
2. [Explanations and discussions of the revised international federation of gynecology and obstetrics staging system 2009].
Shen K; Sun JH; Cao ZY
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):725-31. PubMed ID: 21176550
[No Abstract] [Full Text] [Related]
3. [Prognostic factors in uterine cervical and corpus cancer].
Yoshioka T; Inoue Y; Hoshiai H; Noda K
Gan To Kagaku Ryoho; 1995 Sep; 22(10):1417-22. PubMed ID: 7668881
[TBL] [Abstract][Full Text] [Related]
4. Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer.
Lewin SN; Herzog TJ; Barrena Medel NI; Deutsch I; Burke WM; Sun X; Wright JD
Obstet Gynecol; 2010 Nov; 116(5):1141-9. PubMed ID: 20966700
[TBL] [Abstract][Full Text] [Related]
5. Problematic issues in the staging of endometrial, cervical and vulval carcinomas.
Hirschowitz L; Nucci M; Zaino RJ
Histopathology; 2013 Jan; 62(1):176-202. PubMed ID: 23240675
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and prognostic value of disseminated tumor cells in primary endometrial, cervical and vulvar cancer patients.
Walter CB; Taran FA; Wallwiener M; Rothmund R; Kraemer B; Krawczyk N; Blassl C; Melcher C; Wallwiener D; Fehm T; Hartkopf AD
Future Oncol; 2014 Jan; 10(1):41-8. PubMed ID: 24328408
[TBL] [Abstract][Full Text] [Related]
7. [MR tomography in staging of carcinomas of the uterus].
Scheidler J; Heuck A; Reiser M
Radiologe; 1994 Jul; 34(7):377-83. PubMed ID: 7938485
[TBL] [Abstract][Full Text] [Related]
8. The sentinel node in gynaecological malignancies.
Balega J; Van Trappen PO
Cancer Imaging; 2006 Feb; 6(1):7-15. PubMed ID: 16520291
[TBL] [Abstract][Full Text] [Related]
9. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies.
Echt ML; Finan MA; Hoffman MS; Kline RC; Roberts WS; Fiorica JV
South Med J; 1999 Feb; 92(2):204-8. PubMed ID: 10071668
[TBL] [Abstract][Full Text] [Related]
10. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
[TBL] [Abstract][Full Text] [Related]
11. Revised FIGO staging system for endometrial cancer.
Lewin SN
Clin Obstet Gynecol; 2011 Jun; 54(2):215-8. PubMed ID: 21508690
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical versus surgical staging systems in vulvar cancer.
Shanbour KA; Mannel RS; Morris PC; Yadack A; Walker JL
Obstet Gynecol; 1992 Dec; 80(6):927-30. PubMed ID: 1448261
[TBL] [Abstract][Full Text] [Related]
13. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study).
Homesley HD; Bundy BN; Sedlis A; Yordan E; Berek JS; Jahshan A; Mortel R
Am J Obstet Gynecol; 1991 Apr; 164(4):997-1003; discussion 1003-4. PubMed ID: 2014852
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in gynecologic cancer].
Yajima A; Sato S
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2209-15. PubMed ID: 3408255
[TBL] [Abstract][Full Text] [Related]
15. Revised 1988 International Federation of Gynecology and Obstetrics staging systems for endometrial and vulvar cancer: an assessment.
Homesley HD
Clin Obstet Gynecol; 1992 Mar; 35(1):89-94. PubMed ID: 1544252
[No Abstract] [Full Text] [Related]
16. Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.
Kuwabara Y; Susumu N; Banno K; Hirao T; Kawaguchi M; Yamagami W; Suzuki N; Aoki D; Nozawa S
Jpn J Clin Oncol; 2005 Jan; 35(1):23-7. PubMed ID: 15681600
[TBL] [Abstract][Full Text] [Related]
17. Staging of uterine sarcomas.
Tse KY; Crawford R; Ngan HY
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
[TBL] [Abstract][Full Text] [Related]
18. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
[TBL] [Abstract][Full Text] [Related]
19. [Changes in the TNM classification of gynecological tumors].
Horn LC; Beckmann MW; Beller A; Schmidt D; Ulrich U; Hantschmann P; Wittekind C
Pathologe; 2010 Sep; 31(5):367-73. PubMed ID: 20844876
[TBL] [Abstract][Full Text] [Related]
20. Multimodality imaging of vulvar cancer: staging, therapeutic response, and complications.
Viswanathan C; Kirschner K; Truong M; Balachandran A; Devine C; Bhosale P
AJR Am J Roentgenol; 2013 Jun; 200(6):1387-400. PubMed ID: 23701080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
